ANDA 215600, held by Aurobindo Pharma. Phenoxybenzamine Hydrochloride.
As of Nov 16, 2026, ANDA 215600 (Phenoxybenzamine Hydrochloride), held by Aurobindo Pharma, was first approved by FDA on May 8, 2023, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 8, 2023 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Phenoxybenzamine Hydrochloride10MG ยท capsule;oral | Phenoxybenzamine Hydrochloride | Rx |
| May 8, 2023 | Original application | Approved | None posted |
| May 8, 2023 | Supplement 1 | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters